Targeting CSE Enzyme May Offer New Pathways for Alzheimer’s Treatment

Targeting CSE enzyme may offer new pathways for Alzheimer’s treatment

Scientists at Johns Hopkins Medicine say results of a new National Institutes of Health-funded study are advancing efforts to exploit a new target for Alzheimer's disease: a protein that manufactures an important gas in the brain.

A protein that makes hydrogen sulfide shows potential as a therapeutic target for Alzheimer's disease

Scientists at Johns Hopkins Medicine say results of a new study are advancing efforts to exploit a new target for Alzheimer's disease: a protein that manufactures an important gas in the brain.

‘Fart gas’ linked to memory loss and Alzheimer’s-like brain damage, study finds

Researchers at Johns Hopkins Medicine, led by Bindu Paul, an associate professor of pharmacology, psychiatry and neuroscience at the Johns Hopkins University School of Medicine, reported new evidence that a single brain enzyme may be central to memory. The National Institutes of Health-funded study, in Proceedings of the National Academy of Sciences, focused on cystathionine γ-lyase, or CSE. CSE helps generate tiny amounts of hydrogen sulfide in…

Experiments Advance Potential of Protein That Makes Hydrogen Sulfide as a Therapeutic Target for Alzheimer’s Disease

Scientists at Johns Hopkins Medicine say results of a new National Institutes of Health-funded study are advancing efforts to exploit a new target for Alzheimer’s disease: a protein that manufactures an important gas in the brain.